newsfilter
← Latest News
Business Wire·

Viridian Therapeutics Appoints Jeff Ajer to its Board of Directors

- Mr. Ajer was most recently Chief Commercial Officer at BioMarin - Viridian Therapeutics, Inc. (NASDAQ:VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for